Belgium· BE-AMP-SAM502400-00
Zurampic 200 mg
A lesinurad product containing lesinurad, registered in Belgium by Grünenthal. The same ATC class is registered in 2 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Lesinurad is registered in 2 of 19 countries.
Countries holding a registration under ATC M04AB05 (lesinurad), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 2 of them publish a price we can compare per daily dose
Lesinurad · ATC M04AB05
2 / 19 countries
- Belgiumprice
- Finlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Lesinurad
- Manufacturer
- Grünenthal
- Country
- Belgium (BE)
- ATC code
- M04AB05
- ATC class
- Lesinurad
- Defined daily dose
- 0.2 g, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb3561693
- be_apb7722697
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
102 interactions on record for lesinurad.
Graded by severity as the source publishes them — 100 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Lesinurad · interactions on record
102 records
- 100 moderate
- 2 minor
Most severe, free to view
- AprepitantA04AD12moderate
- MiconazoleA07AC01moderate
- NateglinideA10BX03moderate
- OxandroloneA14AA08moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Lesinurad in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ebe2adbf-d730-49eb-a340-1474ce59cc9f GET /v1/drugs/ebe2adbf-d730-49eb-a340-1474ce59cc9f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "REVOKED",
"name_en": "Zurampic 200 mg",
"name_fr": "Zurampic 200 mg",
"name_nl": "Zurampic 200 mg",
"amp_code": "SAM502400-00",
"strengths": [
"200.0000",
"200.0000"
],
"pack_count": 5,
"substances": [
"Lesinurad"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Lesinurad",
"authorisation_numbers": [
"EU/1/15/1080/003",
"EU/1/15/1080/001",
"EU/1/15/1080/005",
"EU/1/15/1080/002",
"EU/1/15/1080/004"
]
}See everything about lesinurad.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.